| 发明名称 |
Octreotide depot formulation with constantly high exposure levels |
| 摘要 |
The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two different linear polylactide-co-glycolide polymers (PLGAs). |
| 申请公布号 |
AU2009336718(A1) |
申请公布日期 |
2011.06.30 |
| 申请号 |
AU20090336718 |
申请日期 |
2009.12.14 |
| 申请人 |
NOVARTIS AG |
发明人 |
AHLHEIM, MARKUS;PETERSEN, HOLGER |
| 分类号 |
A61K9/52;A61K9/16;A61K38/31;A61K47/10;A61K47/26;A61K47/38 |
主分类号 |
A61K9/52 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
